Original Article

You have free access to this content

Fertility preservation in young women with epithelial ovarian cancer

  1. Jason D. Wright MD1,2,†,*,
  2. Monjri Shah MD1,
  3. Leny Mathew MD3,
  4. William M. Burke MD1,2,4,
  5. Jennifer Culhane MD3,
  6. Noah Goldman MD4,
  7. Peter B. Schiff MD2,5,
  8. Thomas J. Herzog MD1,2

Article first published online: 10 AUG 2009

DOI: 10.1002/cncr.24461

Issue

Cancer

Cancer

Volume 115, Issue 18, pages 4118–4126, 15 September 2009

Additional Information

How to Cite

Wright, J. D., Shah, M., Mathew, L., Burke, W. M., Culhane, J., Goldman, N., Schiff, P. B. and Herzog, T. J. (2009), Fertility preservation in young women with epithelial ovarian cancer. Cancer, 115: 4118–4126. doi: 10.1002/cncr.24461

Author Information

  1. 1

    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York

  2. 2

    Herbert Irving Comprehensive Cancer Center, New York-Presbyterian Hospital/Columbia University Medical Center, New York, New York

  3. 3

    Children's Hospital of Pennsylvania, Philadelphia, Pennsylvania

  4. 4

    Valley Hospital, Ridgewood, New Jersey

  5. 5

    Department of Radiation Oncology, Columbia University College of Physicians and Surgeons, New York, New York

  1. †

    Fax: (212) 305-3412

*Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, 161 Fort Washington Ave, Eighth Floor, New York, NY 10032

Publication History

  1. Issue published online: 4 SEP 2009
  2. Article first published online: 10 AUG 2009
  3. Manuscript Accepted: 18 DEC 2008
  4. Manuscript Revised: 14 DEC 2008
  5. Manuscript Received: 21 OCT 2008

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (174K)

References

  • 1
    Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008; 58: 71-96.
    Direct Link:
  • 2
    Trimbos JB, Parmar M, Vergote I, et al. International Collaborative Ovarian Neoplasm Trial 1 and Adjuvant Chemotherapy in Ovarian Neoplasm trial: 2 parallel randomized phase III trials of adjuvant chemotherapy in patients with early stage ovarian carcinoma. J Natl Cancer Inst. 2003; 95: 105-112.
  • 3
    Trimbos JB, Vergote I, Bolis G, et al. Impact of adjuvant chemotherapy and surgical staging in early stage ovarian carcinoma: European Organization for Research and Treatment of Cancer-Adjuvant Chemotherapy in Ovarian Neoplasm trial. J Natl Cancer Inst. 2003; 95: 113-125.
  • 4
    Young RC, Walton LA, Ellenberg SS, et al. Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of 2 prospective randomized trials. N Engl J Med. 1990; 322: 1021-1027.
  • 5
    Ahmed FY, Wiltshaw E, A'Hern RP, et al. Natural history and prognosis of untreated stage I epithelial ovarian carcinoma. J Clin Oncol. 1996; 14: 2968-2975.
  • 6
    Duska LR, Chang YC, Flynn CE, et al. Epithelial ovarian carcinoma in the reproductive age group. Cancer. 1999; 85: 2623-2629.
    Direct Link:
  • 7
    Plaxe SC, Braly PS, Freddo JL, McClay E, Kirmani S, Howell SB. Profiles of women age 30-39 and age less than 30 with epithelial ovarian cancer. Obstet Gynecol. 1993; 81( 5 pt 1): 651-654.
  • 8
    Smedley H, Sikora K. Age as a prognostic factor in epithelial ovarian carcinoma. Br J Obstet Gynaecol. 1985; 92: 839-842.
    Direct Link:
  • 9
    Swenerton KD, Hislop TG, Spinelli J, LeRiche JC, Yang N, Boyes DA. Ovarian carcinoma: a multivariate analysis of prognostic factors. Obstet Gynecol. 1985; 65: 264-270.
  • 10
    Massi D, Susini T, Savino L, Boddi V, Amunni G, Colafranceschi M. Epithelial ovarian tumors in the reproductive age group: age is not an independent prognostic factor. Cancer. 1996; 77: 1131-1136.
    Direct Link:
  • 11
    Thigpen T, Brady MF, Omura GA, et al. Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experience. Cancer. 1993; 71( 2 suppl): 606-614.
  • 12
    National Cancer Institute, Surveillance, Epidemiology and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 9 registries limited-use, November 2006 submission (1973-2004), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Released April 2007, based on the November 2006 submission. Available at: http://seer.cancer.gov. Accessed October 1, 2007.
  • 13
    National Cancer Institute, Surveillance, Epidemiology and End Results (SEER) Program. The SEER Program, Data Quality. Bethesda, Md: National Cancer Institute; 2007. Available at: http://seer.cancer.gov/about/. Accessed October 1, 2007.
  • 14
    Frey CM, McMillen MM, Cowan CD, Horm JW, Kessler LG. Representativeness of the Surveillance, Epidemiology, and End Results Program data: recent trends in cancer mortality rates. J Natl Cancer Inst. 1992; 84: 872-877.
  • 15
    Zanetta G, Rota SM, Lissoni A, Chiari S, Bratina G, Mangioni C. Conservative treatment followed by chemotherapy with doxorubicin and ifosfamide for cervical sarcoma botryoides in young females. Br J Cancer. 1999; 80( 3-4): 403-406.
  • 16
    Morice P, Wicart-Poque F, Rey A, et al. Results of conservative treatment in epithelial ovarian carcinoma. Cancer. 2001; 92: 2412-2418.
    Direct Link:
  • 17
    Schilder JM, Thompson AM, DePriest PD, et al. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol. 2002; 87: 1-7.
  • 18
    Raspagliesi F, Fontanelli R, Paladini D, di Re EM. Conservative surgery in high-risk epithelial ovarian carcinoma. J Am Coll Surg. 1997; 185: 457-460.
  • 19
    Borgfeldt C, Iosif C, Masback A. Fertility-sparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer. Eur J Obstet Gynecol Reprod Biol. 2007; 134: 110-114.
  • 20
    Chan JK, Teoh D, Hu JM, Shin JY, Osann K, Kapp DS. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol. 2008; 109: 370-376.
  • 21
    Gershenson DM. Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors. J Clin Oncol. 1988; 6: 270-275.
  • 22
    Whitehead E, Shalet SM, Blackledge G, Todd I, Crowther D, Beardwell CG. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease. Cancer. 1983; 52: 988-993.
    Direct Link:
  • 23
    Petrek JA, Naughton MJ, Case LD, et al. Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol. 2006; 24: 1045-1051.
  • 24
    Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause. 2006; 13: 265-279.
  • 25
    Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987; 316: 1105-1110.
  • 26
    Cummings SR, Browner WS, Bauer D, et al. Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1998; 339: 733-738.
  • 27
    Rocca WA, Bower JH, Maraganore DM, et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology. 2007; 69: 1074-1083.
  • 28
    Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol. 2005; 106: 219-226.
  • 29
    Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton LJ3rd. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol. 2006; 7: 821-828.
  • 30
    Cass I, Li AJ, Runowicz CD, et al. Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas. Gynecol Oncol. 2001; 80: 56-61.
  • 31
    Burghardt E, Girardi F, Lahousen M, Tamussino K, Stettner H. Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer. Gynecol Oncol. 1991; 40: 103-106.
  • 32
    Benjamin I, Morgan MA, Rubin SC. Occult bilateral involvement in stage I epithelial ovarian cancer. Gynecol Oncol. 1999; 72: 288-291.
View Full Article (HTML) Get PDF (174K)